Literature DB >> 20847408

Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.

Jon Valla1, Roy Yaari, Andrew B Wolf, Yael Kusne, Thomas G Beach, Alex E Roher, Jason J Corneveaux, Matthew J Huentelman, Richard J Caselli, Eric M Reiman.   

Abstract

In vivo PET imaging studies of young-adult carriers of the apolipoprotein E ε4 allele (APOEε4), the major Alzheimer's disease (AD) susceptibility gene, have demonstrated declines in glucose metabolism in brain areas later vulnerable to AD, such as posterior cingulate cortex, decades before the possible onset of symptoms. We have previously shown in postmortem studies that such metabolic declines in AD are associated with brain regional mitochondrial dysfunction. To determine whether young adult at-risk individuals demonstrate similar mitochondrial functional decline, we histochemically assessed postmortem tissues from the posterior cingulate cortex of young-adult carriers and noncarriers of APOEε4. At-risk ε4 carriers had lower mitochondrial cytochrome oxidase activity than noncarriers in posterior cingulate cortex, particularly within the superficial cortical lamina, a pattern similar to that seen in AD patients. Except for one 34 year-old ε4 homozygote, the ε4 carriers did not have increased soluble amyloid-β, histologic amyloid-β, or tau pathology in this same region. This functional biomarker may prove useful in early detection and tracking of AD and indicates that mitochondrial mechanisms may contribute to the predisposition to AD before any evidence of amyloid or tau pathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20847408      PMCID: PMC3124564          DOI: 10.3233/JAD-2010-100129

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  33 in total

1.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.

Authors:  Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

Authors:  T G Ohm; H Müller; H Braak; J Bohl
Journal:  Neuroscience       Date:  1995-01       Impact factor: 3.590

4.  Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.

Authors:  J Valla; J D Berndt; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

5.  Cytochrome oxidase deficiency in Alzheimer's disease.

Authors:  W D Parker; C M Filley; J K Parks
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

6.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

7.  ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

Authors:  Joyce W Lustbader; Maurizio Cirilli; Chang Lin; Hong Wei Xu; Kazuhiro Takuma; Ning Wang; Casper Caspersen; Xi Chen; Susan Pollak; Michael Chaney; Fabrizio Trinchese; Shumin Liu; Frank Gunn-Moore; Lih-Fen Lue; Douglas G Walker; Periannan Kuppusamy; Zay L Zewier; Ottavio Arancio; David Stern; Shirley ShiDu Yan; Hao Wu
Journal:  Science       Date:  2004-04-16       Impact factor: 47.728

8.  Electron transport chain defects in Alzheimer's disease brain.

Authors:  W D Parker; J Parks; C M Filley; B K Kleinschmidt-DeMasters
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

9.  Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Jessica B S Langbaum; Kewei Chen; Wendy Lee; Cole Reschke; Dan Bandy; Adam S Fleisher; Gene E Alexander; Norman L Foster; Michael W Weiner; Robert A Koeppe; William J Jagust; Eric M Reiman
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

Review 10.  The Alzheimer's disease mitochondrial cascade hypothesis: an update.

Authors:  Russell H Swerdlow; Shaharyar M Khan
Journal:  Exp Neurol       Date:  2009-01-29       Impact factor: 5.330

View more
  77 in total

1.  The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects.

Authors:  Mert R Sabuncu; Randy L Buckner; Jordan W Smoller; Phil Hyoun Lee; Bruce Fischl; Reisa A Sperling
Journal:  Cereb Cortex       Date:  2011-12-13       Impact factor: 5.357

2.  Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.

Authors:  Lisa Mosconi; Juha O Rinne; Wai H Tsui; John Murray; Yi Li; Lidia Glodzik; Pauline McHugh; Schantel Williams; Megan Cummings; Elizabeth Pirraglia; Stanley J Goldsmith; Shankar Vallabhajosula; Noora Scheinin; Tapio Viljanen; Kjell Någren; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2012-04-11       Impact factor: 4.673

Review 3.  The Alzheimer's disease mitochondrial cascade hypothesis.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

Authors:  Julio C Rojas; Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

5.  A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.

Authors:  Adam E Green; Jeremy R Gray; Colin G Deyoung; Timothy R Mhyre; Robert Padilla; Amanda M Dibattista; G William Rebeck
Journal:  Neuropsychologia       Date:  2014-01-02       Impact factor: 3.139

6.  APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.

Authors:  Jesus J Gomar; Marc L Gordon; Dwight Dickinson; Peter B Kingsley; Aziz M Uluğ; Lynda Keehlisen; Sarah Huet; Justin J Buthorn; Jeremy Koppel; Erica Christen; Concepcion Conejero-Goldberg; Peter Davies; Terry E Goldberg
Journal:  Biol Psychiatry       Date:  2013-07-05       Impact factor: 13.382

Review 7.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 8.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

Review 9.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 10.  Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.

Authors:  Konstantinos Ioannis Avgerinos; Grigorios Kalaitzidis; Antonia Malli; Dimitrios Kalaitzoglou; Pavlos Gr Myserlis; Vasileios-Arsenios Lioutas
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.